# Effect of Dexmedetomidine Combined With Sufentanil for Postoperative Intravenous Analgesia in Neurosurgery

Study · id `cardio:ct-nct02552459` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02552459](<https://clinicaltrials.gov/study/NCT02552459>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT02552459

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT02552459. Randomized; single masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT02552459, source copy `cardio:ctgov-nct02552459-2016-10-18`, retrieved 2026-11-18)
- Start date: 2015-09 (registry gives no type) (ClinicalTrials.gov record NCT02552459, source copy `cardio:ctgov-nct02552459-2016-10-18`, retrieved 2026-11-18)
- Primary completion: 2016-12 (anticipated) (ClinicalTrials.gov record NCT02552459, source copy `cardio:ctgov-nct02552459-2016-10-18`, retrieved 2026-11-18)
- Completion: 2016-12 (anticipated) (ClinicalTrials.gov record NCT02552459, source copy `cardio:ctgov-nct02552459-2016-10-18`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT02552459, source copy `cardio:ctgov-nct02552459-2016-10-18`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02552459-2016-10-18`, retrieved 2026-11-18)

## The registry's words

- Brief title: Effect of Dexmedetomidine Combined With Sufentanil for Postoperative Intravenous Analgesia in Neurosurgery
- Condition: Arteriovenous Malformation
- Intervention (Drug): Sufentanil
- Intervention (Drug): dexmedetomidine 1
- Intervention (Drug): dexmedetomidine 2
- Intervention (Drug): dexmedetomidine 3
- Lead sponsor: First Affiliated Hospital, Sun Yat-Sen University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arteriovenous malformation (AVM) (`cardio:arteriovenous-malformation`)
- Registry lists this organization as the lead sponsor: First Affiliated Hospital, Sun Yat-Sen University (`cardio:org-first-affiliated-hospital-sun-yat-sen-university`)

## Provenance

Content hash: 956553d2b1651fb81b258292f5e26b43a9220647bce4c2e8ebb88c120e3aada5
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
